interferon beta-1a
Sign in to saveAlso known as IFN beta 1a, Interferon beta precursor, IFN-beta, Fibroblast interferon, Neoferon
pharmaceutical drug
Chemical data
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Protein
- First approval
- 1996
- Admin. routes
- parenteral
- Indications
- relapsing-remitting multiple sclerosis, ulcerative colitis, hepatitis C virus infection, Crohn's disease
via ChEMBL · EBI
Research
2,731 papers- Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation.Expert review of clinical immunology · 2023
- Interferon beta 1a.Bailliere's clinical neurology · 1997
- Interferon beta-1a for patients with moderate to severe acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials.Polish archives of internal medicine · 2020
- Subcutaneous interferon-beta-1a : new formulation.CNS drugs · 2007
- Interferon beta-1A for multiple sclerosis.Drug and therapeutics bulletin · 1998
via PubMed
Wikidata facts
- Has use
- medication
Show 4 more facts
- route of administration
- intramuscular injection
- defined daily dose
- 4.3
- subject has role
- immunologic adjuvant
- has characteristic
- biopharmaceutical
via Wikidata · CC0
Available in 16 languages
- Français
- Русский
- Português
- Italiano
- العربية
- azb
- Catalan
- Czech
- Hebrew
- Latin
- Nederlands
- Serbian
- Serbian (Latin)
- Tiếng Việt
- فارسی
via Wikidata sitelinks · CC0